BioSpace News Archive

Drug Development

Realizing Gene Therapy and Cell Regeneration in Heart Disease

After decades of treating the big categories of heart disease – hypertension, for example – the ability to address the genetics of heart disease is within sight.

January 23, 2022
·
4 min read
·
Gail Dutton
Drug Development

Aristea is Rehoming Proven Molecules for Rare Inflammatory Diseases

The San Diego-based immunology company is locating and developing molecules where the mechanism of action has either been proven or makes sense.

January 23, 2022
·
5 min read
·
Heather McKenzie
Drug Development

Gilead Withdraws Cancer Drug Amidst Uncompleted Follow-Up Trials

Gilead has announced they are pulling cancer drug Zydelig (idelalisib) off the market for certain types of cancer after failing to complete follow-up clinical trials to confirm efficacy and safety.

January 23, 2022
·
2 min read
·
Hayley Shasteen
Rapid Test Market: Growing need for Rapid Tests to Examine Food Products to Drive the Market

The global rapid test market is anticipated to witness massive growth during the forecast period.

January 23, 2022
·
5 min read
Livestock Pregnancy Testing Devices Market Growth Opportunities – Forecast (2018-2028)

Need to confirm a pregnancy is crucial in animal breeding. It is important to know which ones are getting pregnant and which ones are not in order to determine what the next steps could be.

January 23, 2022
·
7 min read
Global Personalized Cancer Drugs Market Size and Growth Analysis

Genetic sequencing has proven that no two cancer cases are absolutely identical, heavily depending on genetic profiles of the patients, which defines their immunity power.

January 23, 2022
·
6 min read
Oncology Nutrition Market Growth Rate (CAGR) - Forecast (2017 to 2025)

Oncology makes for a field that is consistently evolving owing to great amount of research and development activities are currently underway to formulate therapies and drugs to treat tumors that cause cancer as well as emerge as a result of chemotherapies.

January 23, 2022
·
7 min read
Drug Development

Ascletis Announces First Patient Dosed in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

Ascletis Pharma Inc. announces the dosing of the first patient in the Phase III registration clinical trial of ASC40 combined with bevacizumab for treatment of recurrent glioblastoma.

January 23, 2022
·
5 min read
Policy

Applied Pharmaceutical Science Inc. Announces FDA Approval of Investigational New Drug Application for APS03118, a Next generation RET Original New Drug for Unlimited Cancers

Applied Pharmaceutical Science, Inc., has recently announced the Investigational New Drug application for its self-developed breakthrough new drug APS03118, a next generation selective RET inhibitor, has been approved by the U.S. Food and Drug Administration.

January 23, 2022
·
2 min read
Hormone Replacement Therapy Market: Increase in the Prevalence of Menopausal Disorder to Drive the Market

The global hormone replacement therapy market is estimated to rise at a healthy rate from 2021 to 2031.

January 23, 2022
·
5 min read